Common cough syrup ingredient could cure serious lung disease

The ingredient commonly used in cough syrups could be the key to treating serious lung disease.

Hope in the fight against pulmonary fibrosis

Pulmonary fibrosis is a fatal respiratory disease characterized by scarring of the lungs that impairs oxygen absorption. Recently, a glimmer of hope has emerged for people affected by this devastating disease.

Researchers at the European Molecular Biology Laboratory (EMBL) have discovered that an ingredient found in commonly available cough syrups could be a potential treatment.

A promising discovery

Le Dextromethorphanan active ingredient in cough and cold treatments, has been shown to be effective against pulmonary fibrosis. Scientists used a variety of “omics” technologies and microscopy to identify this ingredient. Their findings were published in the journal Science Translational Medicine.

“It is important to remember that this is still fundamental research and only a very first step in understanding the impact of dextromethorphan on pulmonary fibrosis”said Rainer Pepperkok, head of the EMBL group and lead author of the study.

Understanding pulmonary fibrosis

Pulmonary fibrosis is a condition where lung tissue becomes damaged and scarred, leading to stiffness and difficulty breathing.

Although the exact cause often remains unknown, factors such as long-term exposure to toxins, infections, autoimmune diseases or certain medications can contribute to its development.

Preventing pulmonary fibrosis

Avoiding exposure to known risk factors like smoking, environmental pollutants and hazardous chemicals can reduce risk. Pulmonary fibrosis has no definitive cure, but continued advances in treatment options offer hope for improved quality of life for those affected by this debilitating disease.